REGISTERED NUMBER: 09953365 (England and Wales)

STEM CELL VET LTD

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2025

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTOR:

S Halperin

REGISTERED OFFICE:

1 Abacus House

Newlands Road

Corsham

Wiltshire

SN13 0BH

REGISTERED NUMBER:

09953365 (England and Wales)

ACCOUNTANT:

Clear Vision Accountancy Limited

1 Abacus House

Newlands Road

Corsham

Wiltshire

SN13 0BH

FIXED ASSETS

Tangible assets

4

20,872

25,422

CURRENT ASSETS

Stocks

20,835

6,635

Debtors

5

442,154

372,396

Cash at bank and in hand

567

104

463,556

379,135

CREDITORS

Amounts falling due within one year

6

1,068,492

748,869

NET CURRENT LIABILITIES

(604,936

)

(369,734

)

TOTAL ASSETS LESS CURRENT LIABILITIES

(584,064

)

(344,312

)

CREDITORS

Amounts falling due after more than one year

7

-

13,400

NET LIABILITIES

(584,064

)

(357,712

)

CAPITAL AND RESERVES

Called up share capital

990

1

Retained earnings

(585,054

)

(357,713

)

(584,064

)

(357,712

)

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 15 December 2025 and were signed by:

S Halperin - Director

1.	STATUTORY INFORMATION

Stem Cell Vet Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.

Plant and machinery etc

-

33% on cost, 25% on cost and 25% on reducing balance

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Going concern

The director has assessed whether the company is a going concern and has considered all available information about the future including cashflow forecasts, potential investment opportunities and support from the shareholder. Based on this, they consider the company to be a going concern.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 7 (2024 - 4 ) .

4.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1 July 2024

47,047

Additions

4,762

At 30 June 2025

51,809

DEPRECIATION

At 1 July 2024

21,625

Charge for year

9,312

At 30 June 2025

30,937

NET BOOK VALUE

At 30 June 2025

20,872

At 30 June 2024

25,422

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

Plant and

machinery

etc

£

COST

At 1 July 2024

and 30 June 2025

22,729

DEPRECIATION

At 1 July 2024

5,209

Charge for year

4,380

At 30 June 2025

9,589

NET BOOK VALUE

At 30 June 2025

13,140

At 30 June 2024

17,520

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30/6/25

30/6/24

£

£

Trade debtors

76,872

104,173

Amounts owed by group undertakings

-

184,504

Amounts owed by associates

238,289

-

Other debtors

126,993

83,719

442,154

372,396

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30/6/25

30/6/24

£

£

Bank loans and overdrafts

204,606

78,765

Hire purchase contracts

8,117

7,198

Trade creditors

131,585

149,876

Amounts owed to group undertakings

-

214,942

Amounts owed to associates

451,700

-

Taxation and social security

(27,234

)

(1,413

)

Other creditors

299,718

299,501

1,068,492

748,869

7.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

30/6/25

30/6/24

£

£

Bank loans

-

5,283

Hire purchase contracts

-

8,117

-

13,400

8.	SECURED DEBTS

The following secured debts are included within creditors:

30/6/25

30/6/24

£

£

Bank overdrafts

199,323

36,335

The Company's assets are also held as security against a related Company's bank loan.

9.	DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30 June 2025 and 30 June 2024:

30/6/25

30/6/24

£

£

S Halperin

Balance outstanding at start of year

(243,580

)

(87,845

)

Amounts advanced

213,505

220,736

Amounts repaid

(155,730

)

(376,471

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

(185,805

)

(243,580

)

The Directors Loan Account is included within Creditors and was not overdrawn at any point during the year.

There are no fixed repayment terms and no interest is paid on this loan to the company.

10.	RELATED PARTY DISCLOSURES

During the year loans were made from the following companies, of which Stewart Halperin is the sole director and shareholder. These are included in Creditors within the accounts:

2025

2024

Polden Hills Veterinary Centre Ltd

(£102,201

)

-

H is for Honey Ltd

(£84,491

)

(£75,848

)

C is for Cat Ltd

(£247,946

)

(£133,507

)

Bbounce Ltd

(£12,112

)

(£5,587

)

L is for Lion Limited

(£2,450

)

-

J is for Jaguar Ltd

(£2,500

)

-

During the year loans were made to the following companies, of which Stewart Halperin is the sole director and shareholder. These are included in Debtors within the accounts:

2025

2024

L is for Lion Limited

-

£11,813

G is for Giraffe Limited

£238,289

£172,691

There are no fixed repayment terms and no interest is currently being paid.

11.	SHARE-BASED PAYMENT TRANSACTIONS

Share options of 41 (2024: NIL) are held during the year.

The options can only be exercised whilst the option holder is employed, once notice of termination has been received the options can no longer be exercised. Options are to be vested upon exit only, being a sale of a controlling interest, sale of majority of business or a listing on a stock market.

2025

2024

No.

No.

Outstanding as at 1 July 2024

-

-

Granted during the year

41

-

Forfeited during the year

-

-

Exercised

-

-

Expired during the year

-

-

Outstanding as at 30 June 2025

41

-

Exercisable as at 30 June 2025

-

-